Pantoprazole Ingen Pharma (Pantoprazole Sodium Sesquihydrate)

Pantoprazole is a selective inhibitor of the gastric H+/K+‑ATPase enzyme, commonly called the proton pump, located in the parietal cells of the stomach lining. By binding covalently to the pump in its active state, it blocks the final step of acid production, leading to a sustained decrease in gastric acidity. This reduction allows damaged tissue to heal and diminishes reflux symptoms.

The specific dosage and treatment duration are determined by the prescribing clinician according to the diagnosed condition, patient age, renal function and response to therapy. Common regimens for adults often involve once‑daily oral administration, but the exact strength, frequency and length of therapy must be individualized and written on the prescription.

Pantoprazole is classified as pregnancy category B in many regions, indicating that animal studies have not shown risk but there are limited controlled studies in pregnant women. It should only be used if the potential benefit justifies any potential risk. Small amounts are excreted in breast milk; breastfeeding mothers should consult their physician before use.

To place an order, visit the product page on gnhindia.com, enter the required quantity and submit the inquiry form. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any temperature requirements) and assistance with import documentation.

Pantoprazole shares the same mechanism of action as other proton pump inhibitors such as omeprazole, esomeprazole and lansoprazole, but it has a comparatively lower potential for drug‑drug interactions mediated by CYP2C19. Its pharmacokinetic profile offers consistent acid suppression with once‑daily dosing, and it is often preferred when patients are receiving medications that are metabolized by CYP2C19 pathways.

Pantoprazole tablets should be stored at room temperature, below 25 °C, in the original blister pack or container to protect them from moisture and light. Do not store in bathrooms or near heat sources. Keep out of reach of children and discard any product that shows signs of damage or discoloration.

Pantoprazole is supplied as oral tablets that are taken with water, preferably in the morning before a meal. The tablet should be swallowed whole and not crushed, chewed or split, unless the prescribing information specifically allows it. For patients with a feeding tube, the tablet may be opened and the contents dissolved in a small amount of water, following professional guidance.

Although generally well tolerated, Pantoprazole can be associated with rare but serious adverse events such as severe allergic reactions (including anaphylaxis and Stevens‑Johnson syndrome), Clostridioides difficile‑associated diarrhea, hypomagnesemia, and acute interstitial nephritis. Patients should seek immediate medical attention if they experience rash, swelling, persistent diarrhea, muscle cramps, irregular heartbeat or signs of kidney dysfunction while on therapy.

Pantoprazole is contraindicated in individuals with known hypersensitivity to pantoprazole, other proton pump inhibitors, or any of the tablet excipients. It should also be avoided in patients with a history of severe allergic reactions to PPIs. Caution is advised in patients with severe hepatic impairment, and the drug should be used only under medical supervision in those with known bone metabolism disorders or chronic kidney disease.